X-Ray Repair Cross-Complementing Group 1 (XRCC1) Genetic Polymorphisms and Cervical Cancer Risk: A HuGE Systematic Review and Meta-Analysis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Li, Ya ^a   Liu, Fei ^b   Tan, Shi Qiao ^a   Wang, Yan ^a   Li, Shang Wei ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GLUTAMINE; HISTIDINE; TRYPTOPHAN; XRCC1 PROTEIN;

AGE DISTRIBUTION; ARTICLE; ASIAN; CANCER RISK; CARCINOGENESIS; CHINESE; ETHNIC DIFFERENCE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; PENETRANCE; PROMOTER REGION; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; UTERINE CERVIX CANCER; XRCC1 GENE;

ARGININE; ASIAN CONTINENTAL ANCESTRY GROUP; DNA DAMAGE; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTAMINE; HUMANS; ODDS RATIO; POLYMORPHISM, GENETIC; RISK; RISK FACTORS; TRYPTOPHAN; UTERINE CERVICAL NEOPLASMS;

EID: 84866318916     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044441     Document Type: Article

References (39)

1. Campalans A, Marsin S, Nakabeppu Y, O'connor TR, Boiteux S, et al. (2005) XRCC1 interactions with multiple DNA glycosylases: a model for its recruitment to base excision repair. DNA Repair (Amst) 4: 826-835.
2. Siciliano MJ, Carrano AV, Thompson LH, (1986) Assignment of a human DNA-repair gene associated with sister-chromatid exchange to chromosome19. Mutat Res 174: 303-308.
3. Almeida KH, Sobol RW, (2007) A unified view of base excision repair: lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amst) 6: 695-711.
4. Lamerdin JE, Montgomery MA, Stilwagen SA, Scheidecker LK, Tebbs RS, et al. (1995) Genomic sequence comparison of the human and mouse XRCC1 DNA repair gene regions. Genomics 25: 547-554.
5. Lindahl T, Wood RD, (1999) Quality control by DNA repair. Science (80-) 286: 1897-1905.
6. Shen MR, Jones IM, Mohrenweiser H, (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genesin healthy humans. Cancer Res 58: 604-608.
7. Geng J, Zhang YW, Huang GC, Chen LB, (2008) XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis. World J Gastroenterol 14: 6733-6737.
8. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, et al. (2003) Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 190: 183-190.
9. Seeberg E, Eide L, Bjørås M, (1995) The base excision repair pathway. Trends Biochem Sci 20: 391-397.
10. Vizcaino AP, Moreno V, Bosch FX, Muñoz N, Barros-Dios XM, et al. (2000) International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 86: 429-435.
11. Berumen-Campos J, (2006) Human papilloma virus and cervical cancer. Gac Med Mex 142: 51-59.
12. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
13. Moreno V, Bosch FX, Muñoz N, Meijer CJ, Shah KV, et al. (2002) Effect of oral contraceptives on risk of cervical cancer in women with humanpapillomavirus infection: the IARC multicentric case-control study. Lancet 359: 1085-1092.
14. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12-19.
15. International Agency for Research on Cancer. (2006) IARC monographs on the evaluation of carcinogenic risks to humans, volume 90, human papillomaviruses. Lyon.
16. Niwa Y, Matsuo K, Ito H, Hirose K, Tajima K, et al. (2005) Association of XRCC1 Arg399Gln and OGG1 Ser326Cys polymorphisms with the risk of cervical cancer in Japanese subjects. Gynecol Oncol 99: 43-49.
17. Huang J, Ye F, Chen H, Lu W, Xie X, (2007) The nonsynonymous single nucleotide polymorphisms of DNA repair gene XRCC1 and susceptibility to the development of cervical carcinoma and high-risk human papillomavirus infection. Int J Gynecol Cancer 17: 668-675.
18. Farkasova T, Gurska S, Witkovsky V, Gabelova A, (2008) Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study. Neoplasma 55: 330-337.
19. Settheetham-Ishida W, Yuenyao P, Natphopsuk S, Settheetham D, Ishida T, (2011) Genetic Risk of DNA Repair Gene Polymorphisms (XRCC1 and XRCC3) for High Risk Human Papillomavirus Negative Cervical Cancer in Northeast Thailand. Asian Pac J Cancer Prev 12: 963-966.
20. Barbisan G, Pérez LO, Difranza L, Fernández CJ, Ciancio NE, et al. (2011) XRCC1 Arg399Gln polymorphism and risk for cervical cancer development in Argentine women. Eur J Gynaecol Oncol 32: 274-279.
21. Roszak A, Lianeri M, Jagodzinski PP, (2011) Involvement of the XRCC1 Arg399Gln gene polymorphism in the development of cervicalcarcinoma. Int J Biol Markers 26: 216-220.
22. Wang X, Yang Z, (2010) The relationship of XRCC1 gene polymorphism and the risk of cervical cancer. Modern Medicine & Health 26: 2137-2138.
23. Jiang W, Wang M, Zhang Z, Chen X, Zhu H, et al. (2009) The relationship between XRCC1 polymorphisms and the risk of cervical cancer in Jiangsu population. Acta Universitatis Medicinalis Nanjing(Natural Science) 29: 1-6.
24. Hong Q (2008) Association of ADPRT and XRCC1 gene polymorphisms with susceptibility to squamous cell carcinoma of cervix. Available: http://dlib3.edu.cnki.net/kns50/detail.aspx?dbname=CMFD2009&filename=2009019269.nh. [Article in Chinese].
25. Xiao H, Wu W, Xie H, Bao X, (2010) Relationship between the polymorphism of XRCC1-Arg399Gln and incidence risk of cervical cancer in the population of Guangdong. Hainanmedical Journal 21: 35-37.
26. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta- analyses. BRIT MED J 327: 557-560.
28. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
29. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
30. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
31. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BRIT MED J 315: 629-634.
32. Tudek B, (2007) Base excision repair modulation as a risk factor for human cancers. Mol Aspects Med 28: 258-275.
33. Basso D, Navaglia F, Fogar P, Zambon CF, Greco E, et al. (2007) DNA repair pathways and mitochondrial DNA mutations in gastrointestinalcarcinogenesis. Clin Chim Acta 381: 50-55.
34. Monaco R, Rosal R, Dolan MA, Pincus MR, Brandt-Rauf PW, (2007) Conformational effects of a common codon 399 polymorphism on the BRCT1domain of the XRCC1 protein. Protein J 26: 541-546.
35. Ratnasinghe LD, Abnet C, Qiao YL, Modali R, Stolzenberg-Solomon R, et al. (2004) Polymorphisms of XRCC1 and risk of esophageal and gastric cardia cancer. Cancer Lett 216: 157-164.
36. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, et al. (2006) DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 27: 997-1007.
37. Masson M, Niedergang C, Schreiber V, Muller S, Menissier-de Murcia J, et al. (1998) XRCC1 is specifically associated with poly(ADP-ribose) polymerase and negatively regulates its activity following DNA damage. Mol Cell Biol 18: 3563-3571.
38. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N, (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96: 434-442.
39. Lao T, Gu W, Huang Q, (2008) A meta-analysis on XRCC1 R399Q and R194W polymorphisms, smoking andbladder cancer risk. Mutagenesis 23: 523-532.